Prioritizing R&D Initiatives to Support Cell Line Development (January 2024)

News
Article

Robust, scalable manufacturing of novel therapeutics requires partnering with a CDMO equipped to adapt to changes in the market and knowledgeable on the latest technologies used to support cell line development.

Related Content
© 2024 MJH Life Sciences

All rights reserved.